Results 11 to 20 of about 10,021 (185)

Clinical outcomes of implantation of posterior chamber phakic intraocular lens for pathologic and non-pathologic myopia. [PDF]

open access: yesBMC Ophthalmol, 2023
Background To compare the clinical outcomes of posterior chamber phakic intraocular lens (pIOL) implantation for non-pathological myopia and pathological myopia.
Caixia L   +6 more
europepmc   +2 more sources

Comparison of Non-contact Tonometry and Goldmann Applanation Tonometry Measurements in Non-pathologic High Myopia [PDF]

open access: goldFrontiers in Medicine, 2022
PurposeTo compare intraocular pressure (IOP) values obtained using Goldmann applanation tonometry (IOPGAT) and non-contact tonometry (IOPNCT) in a non-pathologic high myopia population.MethodsA total of 720 eyes from 720 Chinese adults with non ...
Peiyuan Wang   +10 more
doaj   +2 more sources

Global trends and frontiers of research on pathologic myopia since the millennium: A bibliometric analysis. [PDF]

open access: yesFront Public Health, 2022
Background and purposePathologic myopia (PM) is an international public health issue. This study aimed to analyze PM research trends by reporting on publication trends since 2000 and identifying influential journals, countries, authors, and keywords ...
Yang J   +5 more
europepmc   +2 more sources

Key Multimodal Fundus Imaging Findings to Recognize Multifocal Choroiditis in Patients With Pathological Myopia [PDF]

open access: goldFrontiers in Medicine, 2022
Myopia represents a major socioeconomic burden with an increasing prevalence worldwide. Pathologic myopia refers to myopic patients with structural changes in the posterior pole including different patterns of chorioretinal atrophy, choroidal ...
Roberto Gallego-Pinazo   +2 more
doaj   +2 more sources

Novel BMP4 Truncations Resulted in Opposite Ocular Anomalies: Pathologic Myopia Rather Than Microphthalmia. [PDF]

open access: yesFront Cell Dev Biol, 2021
BMP4 variants have been reported to be associated with syndromic microphthalmia (MCOPS6, OMIM 607932). This study aims to describe BMP4 truncation mutations contributing to a novel phenotype in eight patients from four Chinese families.
Jiang Y   +10 more
europepmc   +2 more sources

Use of ranibizumab for the treatment of subretinal neovascularization in pathologic myopia: a prospective study

open access: goldJournal of Ophthalmology, 2016
Purpose: To determine the efficacy of ranibizumab as a treatment for subretinal neovascularization (SRNV) in pathologic myopia. Materials and Methods: This was an uncontrolled, prospective cohort study, involving 66 pathologic myopic eyes (65 patients)
О.M. Blavatska, T.B. Kustry, A.R. Korol
doaj   +2 more sources

Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition. [PDF]

open access: yesSci Rep, 2022
The META-Analysis of Pathologic Myopia Study group proposed a new classification system for myopic maculopathy (MM) with pathologic myopia (PM) defined as MM equal to/more serious than diffuse atrophy or the presence of plus lesions and myopic choroidal ...
Sayanagi K   +7 more
europepmc   +2 more sources

Machine learning prediction of pathologic myopia using tomographic elevation of the posterior sclera. [PDF]

open access: yesSci Rep, 2021
Qualitative analysis of fundus photographs enables straightforward pattern recognition of advanced pathologic myopia. However, it has limitations in defining the classification of the degree or extent of early disease, such that it may be biased by ...
Kim YC   +10 more
europepmc   +2 more sources

Factors associated with the recurrence of choroidal neovascularization in pathologic myopia. [PDF]

open access: yesFront Med (Lausanne), 2022
PurposeTo investigate the factors associated with the recurrence of pathologic myopia choroidal neovascularization (PM-CNV).MethodsForty-eight eyes of 48 patients with PM-CNV treated with conbercept at least 6 months of follow-up were included ...
Jing R, Bo Y, Gao L, Wang Z.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy